ReviewProceedings (Baylor University. Medical Center)2024

The efficacy and safety of cabozantinib in patients with metastatic or advanced renal cell carcinoma: a systematic review and meta-analysis.

Majd M AlBarakat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.